Shamik J. Parikh
CIK: 0001916853
Transaction Breakdown
Open Market Buys (P)1 (25.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HUMA
Humacyte, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 18, 2026HUMA
Humacyte, Inc.
Sale(S)Direct45.9K shares at avg. $0.90$41K - Nov 16, 2025HUMA
Humacyte, Inc.
Award(A)Direct311.1K shares- - Apr 10, 2025HUMA
Humacyte, Inc.
Purchase(P)Direct7.5K shares at avg. $1.55$12K - Jan 21, 2025HUMA
Humacyte, Inc.
Award(A)DirectStock Options (right to buy)
283.1K shares-
1-4 of 4 transactions
About Parikh Shamik J
Parikh Shamik J (SEC CIK 0001916853) files insider reports with the SEC as Chief Medical Officer of Humacyte, Inc. (HUMA).
Signal8 holds 4 ownership filings by Parikh Shamik J, all Form 4s, filed between Jan 23, 2025 and May 20, 2026. Those filings report 4 transactions, from Jan 21, 2025 to May 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Parikh Shamik J's filings is in DURHAM, NC.
Recent filings by Parikh Shamik J
Other insiders filing for Humacyte, Inc. (HUMA)
- COWARD D SCOTT, Director
- Kuznik Paul Brian, Director
- Jones Keith Anthony, Director
- Windham-Bannister Susan Richards, Director
- Constantino Michael T., Director
- Wallace Max N., Director